Hepatitis B vaccination and serious side-effects: Sequence is not consequence;Vaccination anti-hépatite B et effets secondaires graves: Ne pas confondre séquence et conséquence

Gastroenterologie Clinique et Biologique

Volumn 25, Issue 10, 2001, Pages 859-862

  Cales P ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

DEMYELINATING DISEASE; DRUG INDUSTRY; EDITORIAL; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MASS MEDIUM; MEDICOLEGAL ASPECT; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PHILOSOPHY; POLITICS; VACCINATION; VICTIM; VIRUS HEPATITIS;

FRANCE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT, NEWBORN; LIVER NEOPLASMS;

EID: 0035154073     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (27)

1. Vaccination anti-hépatite B: Modalités pratiques et histoire d'une polémique
2. Vaccination anti-hépatite B et risque de sclérose en plaques: Études cas-témoins
3. Central-nervous system demyelinisation after immunisation with recombinant hepatitis B vaccine
4. Retour sur un psychodrame collectif
5. Comparaison entre les risques de premières atteintes démyélinisantes centrales aiguës et les bénéfices de la vaccination contre l'hépatite B
6. A shadow falls on hepatitis B vaccination effort
7. The risk of vaccination. The importance of negative studies
8. Demyelinating disease and hepatitis B vaccination: Is there a link?
9. Adverse events associated with hepatitis B vaccine in U.S. children less than six years of age, 1993 and 1994
10. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices
11. Central nervous system disease in patients with macrophagic myofasciitis
12. Hepatitis B vaccination and the risk of multiple sclerosis
13. Vaccinations and the risk of relapse in multiple sclerosis
14. Vaccination contre l'hépatite B et SEP: Vers la fin d'une polémique
15. Risky business: Challenges in vaccine risk communication
16. Importance of attributable risk in monitoring adverse events after immunization: Hepatitis B vaccination in children
17. The hepatitis B vaccine: Sorting through the B.S. about M.S.
18. Coverage by the news media of the benefits and risks of medications
19. Premier épisode de démyélinisation du système nerveux central et vaccination contre l'hépatite B: Étude cas-témoins pilote
20. Etudes à propos du vaccin hépatite B
21. Do parents understand immunizations? A national telephone survey
22. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
23. Why treat chronic hepatitis B in childhood with interferon α?